Pacific Viscose Limited – Trademark Portfolio
Entity Type: 03
Pacific Viscose Limited holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 23 (Yarns & Threads) — 7 filings in this category. The portfolio also extends into Class 22 (Cordage) across 8 Nice Classification classes. Currently, 3 trademarks are registered and 4 are pending. Notable registered marks include SATERI and ECOCOSY. The owner is based in Central.
21/F, China Building
No. 29 Queen's Road
Central , HK
Showing of trademarks Trademarks
Trademark Classifications
Pacific Viscose Limited's trademark portfolio spans 8 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Pacific Viscose Limited have?
Pacific Viscose Limited has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 pending, 2 abandoned, 1 cancelled.
What trademark classes does Pacific Viscose Limited file in?
Pacific Viscose Limited files trademarks across 8 Nice Classification classes. The most active classes are Class 23 (Yarns & Threads), Class 22 (Cordage), Class 24 (Fabrics), Class 25 (Clothing), Class 5 (Pharmaceuticals). Class 23 covers yarns and threads, for textile use.
What are Pacific Viscose Limited's most well-known trademarks?
Pacific Viscose Limited's registered trademark portfolio includes well-known marks such as SATERI and ECOCOSY. These are among 3 currently registered trademarks in the portfolio.
What is Pacific Viscose Limited's trademark registration success rate?
Pacific Viscose Limited has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 4 applications are pending review.